Header cover image

Swiss (SMI) Pharma Industry Analysis

UpdatedMay 29, 2024
DataAggregated Company Financials
Companies7
  • 7D-2.5%
  • 3M0.7%
  • 1Y-9.4%
  • YTD-2.2%

Over the last 7 days, the Pharma industry has dropped 2.5%, driven by a pullback from Novartis of 3.0%. Overall the industry is down 9.4% in 12 months. As for the next few years, earnings are expected to grow by 12% per annum.

Industry Valuation and Performance

Has the Swiss Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Wed, 29 May 2024CHF406.7bCHF117.3bCHF19.9b40.9x20.4x3.5x
Fri, 26 Apr 2024CHF393.5bCHF113.5bCHF20.0b36.6x19.7x3.5x
Sun, 24 Mar 2024CHF386.2bCHF111.7bCHF19.3b37.5x20x3.5x
Tue, 20 Feb 2024CHF386.3bCHF110.5bCHF19.7b24.2x19.6x3.5x
Thu, 18 Jan 2024CHF416.3bCHF120.2bCHF18.8b27.3x22.2x3.5x
Sat, 16 Dec 2023CHF394.8bCHF120.6bCHF18.8b24.6x21x3.3x
Mon, 13 Nov 2023CHF385.0bCHF122.6bCHF19.1b23.4x20.2x3.1x
Wed, 11 Oct 2023CHF410.2bCHF121.7bCHF18.7b26.6x22x3.4x
Fri, 08 Sep 2023CHF401.9bCHF112.4bCHF18.0b47.6x22.3x3.6x
Sun, 06 Aug 2023CHF409.2bCHF111.4bCHF17.9b48.3x22.9x3.7x
Tue, 04 Jul 2023CHF417.7bCHF115.1bCHF18.9b36.5x22.1x3.6x
Thu, 01 Jun 2023CHF426.7bCHF116.0bCHF19.0b37.4x22.5x3.7x
Sat, 29 Apr 2023CHF429.2bCHF114.9bCHF18.8b41.1x22.8x3.7x
Mon, 27 Mar 2023CHF394.1bCHF116.0bCHF19.0b39.9x20.8x3.4x
Wed, 22 Feb 2023CHF410.1bCHF116.4bCHF19.0b28.4x21.5x3.5x
Fri, 20 Jan 2023CHF435.5bCHF116.7bCHF34.4b23.5x12.6x3.7x
Sun, 18 Dec 2022CHF441.7bCHF117.6bCHF34.8b23.1x12.7x3.8x
Tue, 15 Nov 2022CHF438.6bCHF118.2bCHF35.1b23.2x12.5x3.7x
Thu, 13 Oct 2022CHF443.4bCHF121.5bCHF37.4b20.6x11.9x3.7x
Sat, 10 Sep 2022CHF452.1bCHF119.5bCHF36.6b21.6x12.4x3.8x
Mon, 08 Aug 2022CHF452.8bCHF119.7bCHF36.6b21.1x12.4x3.8x
Wed, 06 Jul 2022CHF448.5bCHF119.1bCHF37.5b27.4x11.9x3.8x
Fri, 03 Jun 2022CHF462.7bCHF118.9bCHF37.4b28.8x12.4x3.9x
Sun, 01 May 2022CHF496.9bCHF119.3bCHF37.6b31.4x13.2x4.2x
Tue, 29 Mar 2022CHF496.4bCHF117.1bCHF36.5b33.4x13.6x4.2x
Thu, 24 Feb 2022CHF468.8bCHF116.4bCHF36.1b19.8x13x4x
Sat, 22 Jan 2022CHF482.2bCHF111.7bCHF23.1b20.6x20.8x4.3x
Mon, 20 Dec 2021CHF497.6bCHF112.2bCHF23.2b21.6x21.4x4.4x
Wed, 17 Nov 2021CHF500.1bCHF112.2bCHF23.2b22.5x21.5x4.5x
Fri, 15 Oct 2021CHF491.3bCHF111.5bCHF22.5b21.8x21.8x4.4x
Sun, 12 Sep 2021CHF487.1bCHF111.6bCHF22.5b21.5x21.7x4.4x
Tue, 10 Aug 2021CHF534.0bCHF111.6bCHF22.5b24.9x23.7x4.8x
Price to Earnings Ratio

21x


Total Market Cap: CHF458.2bTotal Earnings: CHF21.8bTotal Revenue: CHF110.1bTotal Market Cap vs Earnings and Revenue0%0%0%
Swiss Pharma Industry Price to Earnings3Y Average 18.6x202220232024
Current Industry PE
  • Investors are relatively neutral on the Swiss Pharmaceuticals industry at the moment, indicating that they anticipate long term growth rates to remain steady.
  • The industry is trading close to its 3-year average PE ratio of 18.6x.
  • The industry is trading close to its 3-year average PS ratio of 3.8x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have declined 3.0% per year over the last three years.
  • Meanwhile revenues for these companies have grown 2.1% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Trends

Which industries have driven the changes within the Swiss Healthcare industry?

CH Market-0.95%
Healthcare-1.87%
Pharma-2.51%
Pharma-2.51%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
SDZ Sandoz GroupCHF32.290.7%
+CHF90.2m		n/aPE197.3x
KNRS Kinarus Therapeutics HoldingCHF16.135.9%
+CHF213.9k		-66.7%n/a
Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy Policy
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

ROG

CHF228.80

Roche Holding

7D

-1.3%

1Y

-20.6%

NOVN

CHF91.11

Novartis

7D

-2.2%

1Y

4.5%

NWRN

CHF9.60

Newron Pharmaceuticals

7D

-3.3%

1Y

140.0%

SDZ

CHF32.29

Sandoz Group

7D

0.7%

1Y

n/a

Sandoz Group AG (VTX:SDZ) Shares Fly 28% But Investors Aren't Buying For Growth

May 11
Sandoz Group AG (VTX:SDZ) Shares Fly 28% But Investors Aren't Buying For Growth

COPN

CHF71.20

Cosmo Pharmaceuticals

7D

-2.9%

1Y

49.4%

Market Participants Recognise Cosmo Pharmaceuticals N.V.'s (VTX:COPN) Revenues

May 02
Market Participants Recognise Cosmo Pharmaceuticals N.V.'s (VTX:COPN) Revenues

GALD

CHF72.90

Galderma Group

7D

-0.8%

1Y

n/a

KNRS

CHF16.13

Kinarus Therapeutics Holding

7D

5.9%

1Y

-66.7%

DESN

CHF256.00

Dottikon ES Holding

7D

-1.2%

1Y

-1.2%

Subdued Growth No Barrier To Dottikon ES Holding AG's (VTX:DESN) Price

Mar 31
Subdued Growth No Barrier To Dottikon ES Holding AG's (VTX:DESN) Price